Treating reproductive-aged women with glucagon-like peptide-1 receptor agonists: what are the clinical considerations
The hydroxyl radical is especially notorious for causing DNA damage
Unfortunately, Wegovy isnt included in the Novo Nordisk patient assistance program
(12) Macvanin M, Gluvic Z, Radovanovic J, Essack M, Gao X, Isenovic ER
Data were extracted as follows: (1) species, number exposed to drug of interest, number of controls, timing and duration of exposure, dose (drug/kg/time-interval and equivalents to maximum recommended human dosage or clinical dosage), fetal effects of maternal GLP-1 agonist or SGLT2 inhibitor exposure, (2) species, number exposed to drug of interest, number of controls, timing and duration of exposure, dose (drug/kg/time-interval and equivalents to maximum recommended human dosage or clinical dosage), the transfer of GLP-1 agonist or SGLT2 inhibitor in maternal milk and the effect of exposure during lactation on the neonate
Selective inhibition by triacsin C and thiazolidinediones